A functional interferon regulatory factor-1 (IRF-1)-binding site in the upstream regulatory region (URR) of human papillomavirus type 16

被引:14
|
作者
Arany, I
Grattendick, KJ
Whitehead, WE
Ember, IA
Tyring, SK
机构
[1] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA
[2] Univ Texas, Med Branch, Dept Microbiol, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Dept Immunol, Galveston, TX 77555 USA
[4] Univ Pecs, Sch Med, Dept Prevent Med & Public Hlth, H-7643 Pecs, Hungary
[5] Univ Texas, Med Branch, Dept Dermatol, Galveston, TX 77555 USA
关键词
HPV16; transcription; promoter; enhancer; interferon; IRF-1; IRF-E;
D O I
10.1016/S0042-6822(03)00138-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We recently identified a new enhancer element (HIRE-1, HPV-Interferon Responsive Element-1) in the upstream regulatory region (URR) of human papillomavirus (HPV) type 16. HIRE-1 is located upstream from and in close proximity to the TATA box. HIRE-1 is 1 nt shorter in its 5' sequence in comparison to a consensus IRF-1 binding site (IRF-E). Gel shift analyses clearly demonstrated that HIRE-1 is capable of binding IRF-1 in response to interferon-gamma (IFN-gamma) treatment. In a reporter system, HIRE-1 stimulated transcription in response to IRF-1 or IFNgamma from both a heterologous or the homologous (p97) promoter in a dose-dependent manner. Mutations in the core binding sequence strongly decreased this enhancer activity. Interestingly, HIRE-1 stimulated transcription in the context of the full URR in a cell-type-specific manner, thereby suggesting the role of other cell-type-specific factors that might counteract with its function. Thus, our results may explain the inconsistent clinical and experimental results observed following IFN treatment of cervical lesions or cells. Also, this new enhancer may have an important function during inflammatory responses against HPV type 16. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 50 条
  • [21] Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells
    Maratheftis, Christos I.
    Bolaraki, Pelagia E.
    Giannouli, Stavroula
    Kapsogeorgou, Efstathia K.
    Moutsopoulos, Haralampos M.
    Voulgarelis, Michael
    LEUKEMIA RESEARCH, 2006, 30 (09) : 1177 - 1186
  • [22] Molecular cloning and expression analysis of interferon regulatory factor-1 (IRF-1) of turbot and sea bream
    Ordás, MC
    Abollo, E
    Costa, MM
    Figueras, A
    Novoa, B
    MOLECULAR IMMUNOLOGY, 2006, 43 (07) : 882 - 890
  • [23] Interferon regulatory factor-1 (IRF-1) suppression and derepression during endometrial tumorigenesis and cancer progression
    Giatromanolaki, A
    Koukourakis, MI
    Ritis, K
    Mimidis, K
    Sivridis, E
    CYTOKINE, 2004, 26 (04) : 164 - 168
  • [24] Functional Significance of the C-Terminal Domain of Human Interferon Regulatory Factor-1 (IRF-1) in Gene Expression and Cell Cycle Regulation
    Ekta Singh
    Santosh Kumar Mishra
    Rizwanul Haque
    Krishna Prakash
    Iranian Journal of Science, 2024, 48 : 301 - 310
  • [25] The association of interferon regulatory factor-1 (IRF-1) promoter polymorphism with HCV infection and interferon treatment response.
    Promrat, K
    Tang, G
    Dai, W
    Gonzalez, C
    Tong, XM
    Lan, Z
    Ghany, M
    Alter, HJ
    Rotter, JI
    Hoofnagle, JH
    Yang, H
    Liang, TJ
    HEPATOLOGY, 2002, 36 (04) : 282A - 282A
  • [26] Interferon regulatory factor 1(IRF-1) expression in human epidermal keratinocytes and human skin.
    Nakanishi, G
    Fujimoto, W
    Arata, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 608 - 608
  • [27] Functional Significance of the C-Terminal Domain of Human Interferon Regulatory Factor-1 (IRF-1) in Gene Expression and Cell Cycle Regulation
    Singh, Ekta
    Mishra, Santosh Kumar
    Haque, Rizwanul
    Prakash, Krishna
    IRANIAN JOURNAL OF SCIENCE, 2024, 48 (02) : 301 - 310
  • [28] Localization of interferon regulatory factor-1 (IRF-1) in nonpregnant human endometrium: Expression of IRF-1 is up-regulated by prolactin during the secretory phase of the menstrual cycle
    Jabbour, HN
    Critchley, HOD
    Yu-Lee, LY
    Boddy, SC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11): : 4260 - 4265
  • [29] Autoimmune-inflammatory manifestations in human myelodysplasia. A positive correlation with interferon regulatory factor-1 (IRF-1) expression
    Giannouli, S
    Tzoannopoulos, D
    Ritis, K
    Kartalis, G
    Moutsopoulos, HM
    Voulgarelis, M
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 208 - 208
  • [30] Cytokines induce expression of interferon-regulatory factor-1 (IRF-1) in insulin-producing cells
    Flodstrom, M
    Eizirik, DL
    DIABETOLOGIA, 1996, 39 : 384 - 384